Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
R1 RCM ( (RCM) ) has issued an update.
TowerBrook Capital Partners and Clayton, Dubilier & Rice have completed their acquisition of R1 RCM, a leader in healthcare revenue management, making it a privately held company. With this acquisition, valued at approximately $8.9 billion, R1’s common stock will no longer trade on Nasdaq. Joe Flanagan has been reappointed as CEO of R1, aiming to drive innovation and enhance customer value through advanced automation. The deal, supported by major financial institutions, underscores R1’s commitment to transforming healthcare financial performance.
Learn more about RCM stock on TipRanks’ Stock Analysis page.
